Allergen-specific subcutaneous immunotherapy in allergic asthma: immunologic mechanisms and improvement

References

• Maddox L, Schwartz DA. The pathophysiology of asthma. Annu Rev Med. 2002; 53: 477–98.
   PubMed Web of Science ®Google Scholar
• EUROP WHO. Environmental hazards trigger childhood allergic disorders. Fact sheet EURO/01/3. April 2003.
   Google Scholar
• Bosse Y, Hudson TJ. Toward a comprehensive set of asthma susceptibility genes. Annu Rev Med. 2007; 58: 171–84.
   PubMed Web of Science ®Google Scholar
• Carroll W. Asthma genetics: pitfalls and triumphs. Paediatr Respir Rev. 2005; 6: 68–74.
   Google Scholar
• Cookson WO. Asthma genetics. Chest. 2002; 121: S7S–13.
   Web of Science ®Google Scholar
• Holt PG, Thomas WR. Sensitization to airborne environmental allergens: unresolved issues. Nat Immunol. 2005; 6: 957–60.
   PubMed Web of Science ®Google Scholar
• Perry TT, Wood RA, Matsui EC, Curtin-Brosnan J, Rand C, Eggleston PA. Room-specific characteristics of suburban homes as predictors of indoor allergen concentrations. Ann Allergy Asthma Immunol. 2006; 97: 628–35.
   PubMed Web of Science ®Google Scholar
• Trasande L, Thurston GD. The role of air pollution in asthma and other pediatric morbidities. J Allergy Clin Immunol. 2005; 115: 689–99.
   PubMed Web of Science ®Google Scholar
• von Mutius E. The environmental predictors of allergic disease. J Allergy Clin Immunol. 2000; 105: 9–19.
   PubMed Web of Science ®Google Scholar
• Matricardi PM, Rosmini F, Riondino S, Fortini M, Ferrigno L, Rapicetta M, et al.. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ. 2000; 320: 412–7.
   PubMed Web of Science ®Google Scholar
• Tantisira KG, Weiss ST. Childhood infections and asthma: at the crossroads of the hygiene and Barker hypotheses. Respir Res. 2001; 2: 324–7.
   Web of Science ®Google Scholar
• Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax. 2000; 55: S2–10.
   PubMed Web of Science ®Google Scholar
• Noertjojo K, Dimich-Ward H, Obata H, Manfreda J, Chan-Yeung M. Exposure and sensitization to cat dander: asthma and asthma-like symptoms among adults. J Allergy Clin Immunol. 1999; 103: 60–5.
   PubMed Web of Science ®Google Scholar
• Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, et al.. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol. 1988; 140: 4193–8.
   PubMed Web of Science ®Google Scholar
• Van der Pouw Kraan TC, Van der Zee JS, Boeije LC, De Groot ER, Stapel SO, Aarden LA. The role of IL-13 in IgE synthesis by allergic asthma patients. Clin Exp Immunol. 1998; 111: 129–35.
   PubMed Web of Science ®Google Scholar
• Hart PH. Regulation of the inflammatory response in asthma by mast cell products. Immunol Cell Biol. 2001; 79: 149–53.
   PubMed Web of Science ®Google Scholar
• Durham SR. Mechanisms of mucosal inflammation in the nose and lungs. Clin Exp Allergy. 1998; 28: 11–6.
   PubMed Web of Science ®Google Scholar
• Charlesworth EN. Late-phase inflammation: influence on morbidity. J Allergy Clin Immunol. 1996; 98: S291–7.
   Web of Science ®Google Scholar
• Bradding P, Holgate ST. Immunopathology and human mast cell cytokines. Crit Rev Oncol Hematol. 1999; 31: 119–33.
   PubMed Web of Science ®Google Scholar
• Corrigan CJ, Hartnell A, Kay AB. T lymphocyte activation in acute severe asthma. Lancet. 1988; 1: 1129–32.
   PubMed Web of Science ®Google Scholar
• Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JCJr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis. 1992; 146: 109–15.
   PubMed Web of Science ®Google Scholar
• Akbari O, Faul JL, Hoyte EG, Berry GJ, Wahlstrom J, Kronenberg M, et al.. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med. 2006; 354: 1117–29.
   PubMed Web of Science ®Google Scholar
• Akbari O, Stock P, Meyer E, Kronenberg M, Sidobre S, Nakayama T, et al.. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 2003; 9: 582–8.
   PubMed Web of Science ®Google Scholar
• Bilenki L, Yang J, Fan Y, Wang S, Yang X. Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production. Eur J Immunol. 2004; 34: 345–54.
   PubMed Web of Science ®Google Scholar
• Lisbonne M, Diem S, de Castro Keller A, Lefort J, Araujo LM, Hachem P, et al.. Cutting edge: invariant V alpha 14 NKT cells are required for allergen-induced airway inflammation and hyperreactivity in an experimental asthma model. J Immunol. 2003; 171: 1637–41.
   PubMed Web of Science ®Google Scholar
• Das J, Eynott P, Jupp R, Bothwell A, Van Kaer L, Shi Y, et al.. Natural killer T cells and CD8(+) T cells are dispensable for T cell-dependent allergic airway inflammation. Nat Med. 2006; 12: 1345–6.
   PubMed Web of Science ®Google Scholar
• Mutalithas K, Croudace J, Guillen C, Siddiqui S, Thickett D, Wardlaw A, et al.. Bronchoalveolar lavage invariant natural killer T cells are not increased in asthma. J Allergy Clin Immunol. 2007; 119: 1274–6.
   PubMed Web of Science ®Google Scholar
• Vijayanand P, Seumois G, Pickard C, Powell RM, Angco G, Sammut D, et al.. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med. 2007; 356: 1410–22.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989; 7: 145–73.
   PubMed Web of Science ®Google Scholar
• Wierenga EA, Snoek M, Jansen HM, Bos JD, van Lier RA, Kapsenberg ML. Human atopen-specific types 1 and 2 T helper cell clones. J Immunol. 1991; 147: 2942–9.
   PubMed Web of Science ®Google Scholar
• Kapsenberg ML, Hilkens CM, Wierenga EA, Kalinski P. The role of antigen-presenting cells in the regulation of allergen-specific T cell responses. Curr Opin Immunol. 1998; 10: 607–13.
   PubMed Web of Science ®Google Scholar
• Pinto RA, Arredondo SM, Bono MR, Gaggero AA, Diaz PV. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics. 2006; 117: e878–86.
   PubMed Web of Science ®Google Scholar
• Johnson PA, Conway MA, Daly J, Nicolson C, Robertson J, Mills KH. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses. J Gen Virol. 2000; 81: 1737–45.
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986; 136: 2348–57.
   PubMed Web of Science ®Google Scholar
• Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol. 1990; 145: 3796–806.
   PubMed Web of Science ®Google Scholar
• Coyle AJ, Le Gros G, Bertrand C, Tsuyuki S, Heusser CH, Kopf M, et al.. Interleukin-4 is required for the induction of lung Th2 mucosal immunity. Am J Respir Cell Mol Biol. 1995; 13: 54–9.
   PubMed Web of Science ®Google Scholar
• Barner M, Mohrs M, Brombacher F, Kopf M. Differences between IL-4R alpha-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses. Curr Biol. 1998; 8: 669–72.
   PubMed Web of Science ®Google Scholar
• Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989; 245: 308–10.
   PubMed Web of Science ®Google Scholar
• Stafford S, Lowell C, Sur S, Alam R. Lyn tyrosine kinase is important for IL-5-stimulated eosinophil differentiation. J Immunol. 2002; 168: 1978–83.
   PubMed Web of Science ®Google Scholar
• Kapsenberg ML, Jansen HM, Bos JD, Wierenga EA. Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol. 1992; 4: 788–93.
   PubMed Web of Science ®Google Scholar
• Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al.. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med. 1992; 326: 298–304.
   PubMed Web of Science ®Google Scholar
• Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med. 1997; 186: 1737–47.
   PubMed Web of Science ®Google Scholar
• Cohn L, Tepper JS, Bottomly K. IL-4-independent induction of airway hyperresponsiveness by Th2, but not Th1, cells. J Immunol. 1998; 161: 3813–6.
   PubMed Web of Science ®Google Scholar
• Azzawi M, Bradley B, Jeffery PK, Frew AJ, Wardlaw AJ, Knowles G, et al.. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis. 1990; 142: 1407–13.
   PubMed Web of Science ®Google Scholar
• Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe asthma. Relationship to disease severity and atopic status. Am Rev Respir Dis. 1990; 141: 970–7.
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet. 1911; 2: 1572–3.
   Google Scholar
• Cooke R. Hay fever and asthma: the uses and limitations of desensitization. NY Med J. 1918; 107: 577–83.
   Google Scholar
• Arsdel PJV, Middleton EJ. the effect of hyposensitization on the in vitro histamine release by specific antigen. J Allergy. 1961; 32: 348–56.
   Google Scholar
• Lichtenstein LM, Osler AG. Studies on the mechanisms of hypersensitivity phenomena. XII. An in vitro study of the reaction between ragweed pollen antigen, allergic human serum and ragweed-sensitive human leukocytes. J Immunol. 1966; 96: 169–79.
   Web of Science ®Google Scholar
• Bousquet J, Michel FB. Specific immunotherapy in asthma: is it effective?. J Allergy Clin Immunol. 1994; 94: 1–11.
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am J Respir Crit Care Med. 1995; 151: 969–74.
   PubMed Web of Science ®Google Scholar
• Bousquet J. Pro: immunotherapy is clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med. 2001; 164: 2139–40. (Discussion 41–2).
   PubMed Web of Science ®Google Scholar
• Adkinson NF Jr . Con: immunotherapy is not clinically indicated in the management of allergic asthma. Am J Respir Crit Care Med. 2001; 164: 2140–1. (Discussion 1–2).
   Web of Science ®Google Scholar
• Abramson M, Puy R, Weiner J. Immunotherapy in asthma: an updated systematic review. Allergy. 1999; 54: 1022–41.
   PubMed Web of Science ®Google Scholar
• Abramson MJ , Puy RM , Weiner JM . Allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2000; CD001186.
   Google Scholar
• Djurup R. The subclass nature and clinical significance of the IgG antibody response in patients undergoing allergen-specific immunotherapy. Allergy. 1985; 40: 469–86.
   PubMed Web of Science ®Google Scholar
• Creticos PS, Van Metre TE, Mardiney MR, Rosenberg GL, Norman PS, Adkinson NFJr. Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol. 1984; 73: 94–104.
   PubMed Web of Science ®Google Scholar
• Gehlhar K, Schlaak M, Becker W, Bufe A. Monitoring allergen immunotherapy of pollen-allergic patients: the ratio of allergen-specific IgG4 to IgG1 correlates with clinical outcome. Clin Exp Allergy. 1999; 29: 497–506.
   PubMed Web of Science ®Google Scholar
• Jakobsen CG, Bodtger U, Poulsen LK, Roggen EL. Vaccination for birch pollen allergy: comparison of the affinities of specific immunoglobulins E, G1 and G4 measured by surface plasmon resonance. Clin Exp Allergy. 2005; 35: 193–8.
   PubMed Web of Science ®Google Scholar
• Wachholz PA, Durham SR. Induction of ‘blocking’ IgG antibodies during immunotherapy. Clin Exp Allergy. 2003; 33: 1171–4.
   PubMed Web of Science ®Google Scholar
• Nouri-Aria KT, Wachholz PA, Francis JN, Jacobson MR, Walker SM, Wilcock LK, et al.. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity. J Immunol. 2004; 172: 3252–9.
   PubMed Web of Science ®Google Scholar
• van Neerven RJ, Wikborg T, Lund G, Jacobsen B, Brinch-Nielsen A, Arnved J, et al.. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol. 1999; 163: 2944–52.
   PubMed Web of Science ®Google Scholar
• Flicker S, Valenta R. Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol. 2003; 132: 13–24.
   PubMed Web of Science ®Google Scholar
• Wachholz PA, Durham SR. Mechanisms of immunotherapy: IgG revisited. Curr Opin Allergy Clin Immunol. 2004; 4: 313–8.
   PubMed Web of Science ®Google Scholar
• Gudmundsdottir H, Turka LA. T cell costimulatory blockade: new therapies for transplant rejection. J Am Soc Nephrol. 1999; 10: 1356–65.
   Web of Science ®Google Scholar
• Gao JX, Madrenas J, Zeng W, Cameron MJ, Zhang Z, Wang JJ, et al.. CD40-deficient dendritic cells producing interleukin-10, but not interleukin-12, induce T-cell hyporesponsiveness in vitro and prevent acute allograft rejection. Immunology. 1999; 98: 159–70.
   Web of Science ®Google Scholar
• Kobata T, Azuma M, Yagita H, Okumura K. Role of costimulatory molecules in autoimmunity. Rev Immunogenet. 2000; 2: 74–80.
   PubMedGoogle Scholar
• Wells AD, Walsh MC, Bluestone JA, Turka LA. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy. J Clin Invest. 2001; 108: 895–903.
   PubMed Web of Science ®Google Scholar
• Ebner C, Siemann U, Bohle B, Willheim M, Wiedermann U, Schenk S, et al.. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl a major grass pollen allergen. Clin Exp Allergy. 1997; 27: 1007–15.
   PubMed Web of Science ®Google Scholar
• Moverare R, Elfman L, Bjornsson E, Stalenheim G. Cytokine production by peripheral blood mononuclear cells following birch-pollen immunotherapy. Immunol Lett. 2000; 73: 51–6.
   PubMed Web of Science ®Google Scholar
• Bahceciler NN, Isik U, Barlan IB, Basaran MM. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study. Pediatr Pulmonol. 2001; 32: 49–55.
   PubMed Web of Science ®Google Scholar
• Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001; 31: 1392–7.
   PubMed Web of Science ®Google Scholar
• Jenkins MK, Schwartz RH. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med. 1987; 165: 302–19.
   PubMed Web of Science ®Google Scholar
• Schwartz RH. Models of T cell anergy: is there a common molecular mechanism?. J Exp Med. 1996; 184: 1–8.
   PubMed Web of Science ®Google Scholar
• Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med. 1998; 187: 177–83.
   PubMed Web of Science ®Google Scholar
• Taams LS, van Rensen AJ, Poelen MC, van Els CA, Besseling AC, Wagenaar JP, et al.. Anergic T cells actively suppress T cell responses via the antigen-presenting cell. Eur J Immunol. 1998; 28: 2902–12.
   Web of Science ®Google Scholar
• Jutel M, Pichler WJ, Skrbic D, Urwyler A, Dahinden C, Muller UR. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures. J Immunol. 1995; 154: 4187–94.
   PubMed Web of Science ®Google Scholar
• Secrist H, Chelen CJ, Wen Y, Marshall JD, Umetsu DT. Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals. J Exp Med. 1993; 178: 2123–30.
   PubMed Web of Science ®Google Scholar
• Varney VA, Hamid QA, Gaga M, Ying S, Jacobson M, Frew AJ, et al.. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses. J Clin Invest. 1993; 92: 644–51.
   PubMed Web of Science ®Google Scholar
• McHugh SM, Deighton J, Stewart AG, Lachmann PJ, Ewan PW. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy. Clin Exp Allergy. 1995; 25: 828–38.
   PubMed Web of Science ®Google Scholar
• Kowalski ML, Jutel M. Mechanisms of specific immunotherapy of allergic diseases. Allergy. 1998; 53: 485–92.
   Web of Science ®Google Scholar
• O'Brien RM, Byron KA, Varigos GA, Thomas WR. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes. Clin Exp Allergy. 1997; 27: 46–51.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Akdis M, Blesken T, Wymann D, Alkan SS, Muller U, et al.. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J Clin Invest. 1996; 98: 1676–83.
   PubMed Web of Science ®Google Scholar
• Vissers JL, van Esch BC, Hofman GA, Kapsenberg ML, Weller FR, van Oosterhout AJ. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J Allergy Clin Immunol. 2004; 113: 1204–10.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest. 1998; 102: 98–106.
   PubMed Web of Science ®Google Scholar
• Francis JN, Till SJ, Durham SR. Induction of IL-10 + CD4 + CD25+ T cells by grass pollen immunotherapy. J Allergy Clin Immunol. 2003; 111: 1255–61.
   PubMed Web of Science ®Google Scholar
• Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, et al.. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol. 2003; 33: 1205–14.
   PubMed Web of Science ®Google Scholar
• Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F. CD4 + CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J Exp Med. 2003; 197: 111–9.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, et al.. Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev. 2001; 182: 18–32.
   PubMed Web of Science ®Google Scholar
• Suri-Payer E, Amar AZ, Thornton AM, Shevach EM. CD4 + CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol. 1998; 160: 1212–8.
   PubMed Web of Science ®Google Scholar
• Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995; 155: 1151–64.
   PubMed Web of Science ®Google Scholar
• Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, et al.. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001; 27: 68–73.
   PubMed Web of Science ®Google Scholar
• Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4 + CD25+ regulatory T cells. Nat Immunol. 2003; 4: 330–6.
   PubMed Web of Science ®Google Scholar
• Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4 + CD25+ T regulatory cells. Nat Immunol. 2003; 4: 337–42.
   PubMed Web of Science ®Google Scholar
• Wildin RS, Ramsdell F, Peake J, Faravelli F, Casanova JL, Buist N, et al.. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001; 27: 18–20.
   PubMed Web of Science ®Google Scholar
• Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006; 24: 209–26.
   PubMed Web of Science ®Google Scholar
• Cederbom L, Hall H, Ivars F. CD4 + CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol. 2000; 30: 1538–43.
   PubMed Web of Science ®Google Scholar
• Thornton AM, Shevach EM. CD4 + CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med. 1998; 188: 287–96.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med. 2002; 196: 255–60.
   PubMed Web of Science ®Google Scholar
• Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and induced CD4 + CD25+ cells educate CD4 + CD25-cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol. 2004; 172: 5213–21.
   PubMed Web of Science ®Google Scholar
• Mekala DJ, Alli RS, Geiger TL. IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4 + CD25+ T lymphocytes. Proc Natl Acad Sci USA. 2005; 102: 11817–22.
   PubMed Web of Science ®Google Scholar
• Akdis CA, Blaser K. Role of IL-10 in allergen-specific immunotherapy and normal response to allergens. Microbes Infect. 2001; 3: 891–8.
   PubMed Web of Science ®Google Scholar
• Grunig G, Corry DB, Leach MW, Seymour BW, Kurup VP, Rennick DM. Interleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J Exp Med. 1997; 185: 1089–99.
   PubMed Web of Science ®Google Scholar
• Zuany-Amorim C, Haile S, Leduc D, Dumarey C, Huerre M, Vargaftig BB, et al.. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J Clin Invest. 1995; 95: 2644–51.
   PubMed Web of Science ®Google Scholar
• Hagenbaugh A, Sharma S, Dubinett SM, Wei SH, Aranda R, Cheroutre H, et al.. Altered immune responses in interleukin 10 transgenic mice. J Exp Med. 1997; 185: 2101–10.
   PubMed Web of Science ®Google Scholar
• Van Oosterhout AJ, Van Esch B, Hofman G, Hofstra CL, Van Ark I, Nijkamp FP, et al.. Allergen immunotherapy inhibits airway eosinophilia and hyperresponsiveness associated with decreased IL-4 production by lymphocytes in a murine model of allergic asthma. Am J Respir Cell Mol Biol. 1998; 19: 622–8.
   Web of Science ®Google Scholar
• Jeannin P, Lecoanet S, Delneste Y, Gauchat JF, Bonnefoy JY. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol. 1998; 160: 3555–61.
   PubMed Web of Science ®Google Scholar
• Royer B, Varadaradjalou S, Saas P, Guillosson JJ, Kantelip JP, Arock M. Inhibition of IgE-induced activation of human mast cells by IL-10. Clin Exp Allergy. 2001; 31: 694–704.
   PubMed Web of Science ®Google Scholar
• de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, et al.. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991; 174: 915–24.
   PubMed Web of Science ®Google Scholar
• Ding L, Linsley PS, Huang LY, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol. 1993; 151: 1224–34.
   PubMed Web of Science ®Google Scholar
• Kawamura T, Furue M. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur J Immunol. 1995; 25: 1913–7.
   Web of Science ®Google Scholar
• Schandene L, Alonso-Vega C, Willems F, Gerard C, Delvaux A, Velu T, et al.. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol. 1994; 152: 4368–74.
   PubMed Web of Science ®Google Scholar
• Kitani A, Fuss I, Nakamura K, et al.. Transforming growth factor (TGF)-beta1-producing regulatory T cells induce Smad-mediated interleukin 10 secretion that facilitates coordinated immunoregulatory activity and amelioration of TGF-beta1-mediated fibrosis. J Exp Med. 2003; 198: 1179–88.
   PubMed Web of Science ®Google Scholar
• Blaser K, Akdis CA. Interleukin-10, T regulatory cells and specific allergy treatment. Clin Exp Allergy. 2004; 34: 328–31.
   PubMed Web of Science ®Google Scholar
• Kapsenberg ML. Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol. 2003; 3: 984–93.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998; 392: 245–52.
   PubMed Web of Science ®Google Scholar
• Lutz MB, Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol. 2002; 23: 445–9.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001; 193: 233–8.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Steinbrink K, Enk AH. Dendritic cells as a tool to induce anergic and regulatory T cells. Trends Immunol. 2001; 22: 394–400.
   PubMed Web of Science ®Google Scholar
• Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, et al.. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 1995; 373: 531–6.
   PubMed Web of Science ®Google Scholar
• Martin E, O'Sullivan B, Low P, Thomas R. Antigen-specific suppression of a primed immune response by dendritic cells mediated by regulatory T cells secreting interleukin-10. Immunity. 2003; 18: 155–67.
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G, Giarratana N, Roncari A, Amuchastegui S, Daniel KC, et al.. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004; 89–90: 437–41.
   PubMed Web of Science ®Google Scholar
• de Jong EC, Vieira PL, Kalinski P, Kapsenberg ML. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol. 1999; 66: 201–4.
   PubMed Web of Science ®Google Scholar
• Lee JI, Ganster RW, Geller DA, Burckart GJ, Thomson AW, Lu L. Cyclosporine A inhibits the expression of costimulatory molecules on in vitro-generated dendritic cells: association with reduced nuclear translocation of nuclear factor kappa B. Transplantation. 1999; 68: 1255–63.
   PubMed Web of Science ®Google Scholar
• Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, et al.. Direct transcriptional regulation of RelB by 1alpha,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem. 2003; 278: 49378–85.
   PubMed Web of Science ®Google Scholar
• Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001; 167: 1945–53.
   PubMed Web of Science ®Google Scholar
• Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002; 51: 1367–74.
   PubMed Web of Science ®Google Scholar
• Belladonna ML, Grohmann U, Guidetti P, Volpi C, Bianchi R, Fioretti MC, et al.. Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. J Immunol. 2006; 177: 130–7.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, et al.. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol. 2006; 176: 6752–61.
   PubMed Web of Science ®Google Scholar
• Grohmann U, Fallarino F, Bianchi R, Belladonna ML, Vacca C, Orabona C, et al.. IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. J Immunol. 2001; 167: 708–14.
   PubMed Web of Science ®Google Scholar
• Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, et al.. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science. 2002; 297: 1867–70.
   PubMed Web of Science ®Google Scholar
• Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, et al.. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science. 1998; 281: 1191–3.
   PubMed Web of Science ®Google Scholar
• Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, et al.. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol. 2002; 3: 1097–101.
   PubMed Web of Science ®Google Scholar
• Grohmann U, Fallarino F, Bianchi R, Orabona C, Vacca C, Fioretti MC, et al.. A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice. J Exp Med. 2003; 198: 153–60.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al.. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003; 4: 1206–12.
   PubMed Web of Science ®Google Scholar
• Orabona C, Grohmann U, Belladonna ML, Fallarino F, Vacca C, Bianchi R, et al.. CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. Nat Immunol. 2004; 5: 1134–42.
   PubMed Web of Science ®Google Scholar
• Frumento G, Rotondo R, Tonetti M, Damonte G, Benatti U, Ferrara GB. Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase. J Exp Med. 2002; 196: 459–68.
   PubMed Web of Science ®Google Scholar
• Terness P, Bauer TM, Rose L, Dufter C, Watzlik A, Simon H, et al.. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med. 2002; 196: 447–57.
   PubMed Web of Science ®Google Scholar
• Taher YA, Piavaux BJA, Gras R, Esch BCAMv, Hofman GA, Bloksma N, et al.. Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J Allergy Clin Immunol. 2008; 121: 983–91.
   PubMed Web of Science ®Google Scholar
• Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol. 1989; 83: 797–802.
   PubMed Web of Science ®Google Scholar
• Greineder DK. Risk management in allergen immunotherapy. J Allergy Clin Immunol. 1996; 98: S330–4.
   Web of Science ®Google Scholar
• Taher YA, van Esch BC, Hofman G, Henricks PAJ, Van Oosterhout AJ. 1alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol. 2008; 180: 5211–21.
   PubMed Web of Science ®Google Scholar